Company Profile
BioVie Inc. Stock Price, News & Catalysts
- Ticker:
- BIVI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.56 USD (+22.83%)
Close
Last updated: August 12, 2026
12.8M USD
Market cap
Why the stock is moving
As of Aug 12, 2026, BIVI closed up 22.8% at $1.56. No new same-company headline was identified in the current news window.
Company overview
Business overview
BioVie is a biotechnology company focused on neurodegeneration, inflammation, and chronic disease biology. Its story has centered on trying to build a therapeutic platform in areas with large unmet need but high development risk.
Geographic Base and Sector Classification
BioVie is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
Business Model Characteristics
The company depends on clinical progress, strategic focus, and financing discipline. Investors usually watch early data, pipeline direction, and whether the company can preserve enough runway.
Position Within the Biotechnology Landscape
BioVie occupies a speculative small-cap biotech niche. It is a catalyst-sensitive story where the market is still waiting for a clear clinical breakthrough.
Future catalysts
- BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path. The next step matters because the company still needs a strong human-data signal.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of BioVie Inc. (BIVI)?
BioVie Inc. (BIVI) most recently closed at 1.56 USD, a +22.83% move versus the previous session.
What is the market cap of BioVie Inc. (BIVI)?
BioVie Inc. currently has a market capitalization of 12.8M USD on BioPharmSignal.
What does BioVie Inc. do?
BioVie is a biotechnology company focused on neurodegeneration, inflammation, and chronic disease biology. Its story has centered on trying to build a therapeutic platform in areas with large unmet need but high development risk.
On which exchange is BIVI stock listed?
BioVie Inc. (BIVI) is associated with NASDAQ, United States, Biopharma.
What is BioVie?
BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path.
Which conditions is BioVie Inc. targeting with BioVie?
BioVie Inc. is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does BioVie Inc. describe recent progress with BioVie?
BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path.
What future catalysts are investors watching for BioVie Inc.?
BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path. The next step matters because the company still needs a strong human-data signal.